Heartburn · Patients with gastro‐oesophageal reflux disease (GORD) in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reflux · Patients with gastro‐oesophageal reflux disease (GORD) in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Failure rate of post‐pyloric placement of the enteral feeding tube assessed by abdominal radiograph Radiographic assessment of successful tube placement · patients needing post‐pyloric placement of naso‐enteral feeding tubes
It is very uncertain whether the intervention changes failure rate of post‐pyloric placement of the enteral feeding tube… (very low certainty).
1 finding from 1 review
Endoscopic remission · patients with induction of remission in ulcerative colitis
It is very uncertain whether LMWH changes endoscopic remission compared with placebo (very low certainty).
1 finding from 1 review
Clinical remission · patients with induction of remission in ulcerative colitis
It is very uncertain whether LMWH + standard therapy changes clinical remission compared with standard therapy (very low certainty).
1 finding from 1 review
Clinical improvement · patients with induction of remission in ulcerative colitis
It is very uncertain whether LMWH + standard therapy changes clinical improvement compared with standard therapy (very low certainty).
1 finding from 1 review
Endoscopic remission · patients with induction of remission in ulcerative colitis
It is very uncertain whether LMWH + standard therapy changes endoscopic remission compared with standard therapy (very low certainty).
1 finding from 1 review
Endoscopic improvement (dichotomous) · patients with induction of remission in ulcerative colitis
It is very uncertain whether LMWH + standard therapy changes endoscopic improvement compared with standard therapy (very low certainty).
1 finding from 1 review
Clinical improvement · patients with induction of remission in ulcerative colitis
It is very uncertain whether UFH changes clinical improvement compared with corticosteroids (very low certainty).
1 finding from 1 review
Remission · patients with induction of remission in ulcerative colitis
Type I Interferons showed no clear difference in remission compared with placebo (moderate certainty).
1 finding from 1 review
Clinical improvement · patients with induction of remission in ulcerative colitis
Type I Interferons showed no clear difference in clinical improvement compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · patients with induction of remission in ulcerative colitis
Type I Interferons showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with induction of remission in ulcerative colitis
Type I Interferons may leads to higher withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Maintenance of remission · Patients with quiescent ulcerative colitis
Methotrexate showed no clear difference in maintenance of remission compared with placebo (low certainty).
1 finding from 1 review
Maintenance of remission · Patients with quiescent ulcerative colitis
It is very uncertain whether methotrexate changes maintenance of remission compared with 5‐ASA (very low certainty).
1 finding from 1 review
RR 1.12 [0.06, 20.71]
1 study · 9 participants
Very low
Maintenance of remission · Maintenance of remission in ulcerative colitis
It is very uncertain whether methotrexate changes maintenance of Remission compared with 6‐MP (very low certainty).
1 finding from 1 review
Maintenance of remission · Maintenance of remission in ulcerative colitis
It is very uncertain whether methotrexate + sulfasalazine changes maintenance of Remission compared with sulfasalazine (very low certainty).
1 finding from 1 review
Remission (combined clinical and endoscopic remission) · Adult patients with active ulcerative colitis
Budesonide MMX® 9 mg probably leads to higher remission (combined clinical and endoscopic remission) compared with placebo (moderate certainty).
1 finding from 1 review
Endoscopic improvement (dichotomous) · Adult patients with active ulcerative colitis
Budesonide MMX® 6 mg showed no clear difference in endoscopic improvement compared with placebo (moderate certainty).
1 finding from 1 review
Histologic remission · Adult patients with active ulcerative colitis
Budesonide MMX® 6 mg showed no clear difference in histologic remission compared with placebo (low certainty).
1 finding from 1 review